FDA president and Executive Committee elections 2020

Nominations are now open for the election of the FDA president and members of the FDA Executive Committee. As members of both the FDA and UNISON, MiP members are entitled to stand for election, nominate candidates and vote in both elections.
FDA Executive Committee
MiP has four seats on the FDA Executive Committee. MiP members can only nominate candidates from within the MiP constituency, and each nomination must be signed by at least two MiP members or by the MiP National Committee. If more than four candidates are nominated, a postal ballot will be held. Members elected to represent the MiP constituency will serve for a two-year term, from 1 June 2020 to 31 May 2022.
You can download the nomination form for the Executive Committee elections here.
FDA President
MiP members can also nominate candidates, from any constituency of the FDA, for the post of the FDA president. Candidates will need at least 30 nominations to stand, including at least five from three different constituencies. If more than one candidate is successfully nominated, a postal ballot will be held. The president will service a two-year term, from 1 June 2020 to 31 May 2022.
You can download the nomination form for the election of the FDA president here.
Nominations for both elections close at 5pm on Friday 6 March 2020.
You can read more about the FDA’s structure and the role of the president and Executive Committee on the FDA’s website.
Related News
-

Government must “come clean” about NHS shake-up, says MiP
A year after it ordered tens of thousands of job cuts in the NHS in England, MiP is urging the government to “come clean” about how the NHS will be run after the changes.
-

Back to office order reversed after unions and staff protest
NHS England has “paused” its demand for staff to work in the office for at least 60% of their working time following opposition from staff and trade unions.
-

Government proposal for sub-inflation pay rise “not good enough”, says MiP
Pay rises for most NHS staff should be restricted to an “affordable” 2.5% next year to deliver improvements to NHS services and avoid “difficult” trade-offs, the UK government has said.